Philippe Rémy

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

Philippe Rémy, M Doder, Andrew J. Lees et al. · Brain · 2005 · 1K citations · Full text

Neurotransmitter, Psychopharmacology, High Frequency +23

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study

Alan Whone, Ray L. Watts, A. Jon Stoessl et al. · Annals of Neurology · 2003 · 825 citations

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

Frédéric Houssiau, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2010 · 489 citations · Full text

Motor and cognitive improvements in patients with Huntington's disease after neural transplantation

Anne‐Catherine Bachoud‐Lévi, Philippe Rémy, Jean‐Paul Nguyen et al. · The Lancet · 2000 · 454 citations

Neurorehabilitation, Neuropsychology, Neurological Disorder +12

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

Gene Therapies, Neurodegenerative Diseases, Dose Escalation +11